8-((6-Iodobenzo[d][1,3]dioxol-5-yl)thio)-9H-purin-6-amine

Catalog No. :
ACPBLO405
CAS No. :
873436-89-6
Molecular Formula :
C12H8IN5O2S
Molecular Weight :
413.20

IUPAC Name:8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio)-9H-purin-6-amine

8-((6-Iodobenzo[d][1,3]dioxol-5-yl)thio)-9H-purin-6-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$788.00Login to see priceInquiryInquiry
1g97%$1970.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-((6-Iodobenzo[d][1,3]dioxol-5-yl)thio)-9H-purin-6-amine
IUPAC Name8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio)-9H-purin-6-amine
MDL No.MFCD25968211
Molecular FormulaC12H8IN5O2S
Molecular Weight413.20
SMILESNC1=C2N=C(SC3=C(I)C=C(OCO4)C4=C3)NC2=NC=N1
InChI KeyBFOWGJNWQLLISB-UHFFFAOYSA-N
Synonym8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio)-9H-purin-6-amine;9H-Purin-6-amine, 8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-;8-[(6-Iodo-1,3-benzodioxol-5-yl)thio]-9H-purin-6-amine
CAS No.873436-89-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPBLO405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTHSJ081 route compound structure diagram
    ACTHSJ0815876-52-8 In Stock
  2. Plus
  3. ACZPOE257 route compound structure diagram
    ACZPOE2577390-62-7 In Stock
  4. Then
  5. ACPBLO405 route product structure diagram
    ACPBLO405873436-89-6
Inquiry

2. ACPBLO405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKZOY421 route compound structure diagram
    ACKZOY4216974-78-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPBLO405 route product structure diagram
    ACPBLO405873436-89-6
Inquiry

Comments (0)